- Home
- IPHA vs FLXS Comparison
IPHA vs FLXS Comparison
Compare IPHA & FLXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- FLXS
- Stock Information
- Founded
- IPHA 1999
- FLXS 2001
- Country
- IPHA France
- FLXS United States
- Employees
- IPHA N/A
- FLXS N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- FLXS Home Furnishings
- Sector
- IPHA Health Care
- FLXS Consumer Discretionary
- Exchange
- IPHA Nasdaq
- FLXS Nasdaq
- Market Cap
- IPHA 160.1M
- FLXS 175.4M
- IPO Year
- IPHA 2019
- FLXS N/A
- Fundamental
- Price
- IPHA $1.74
- FLXS $37.87
- Analyst Decision
- IPHA Strong Buy
- FLXS
- Analyst Count
- IPHA 1
- FLXS 0
- Target Price
- IPHA $11.00
- FLXS N/A
- AVG Volume (30 Days)
- IPHA 11.2K
- FLXS 31.7K
- Earning Date
- IPHA 09-11-2025
- FLXS 08-18-2025
- Dividend Yield
- IPHA N/A
- FLXS 1.71%
- EPS Growth
- IPHA N/A
- FLXS N/A
- EPS
- IPHA N/A
- FLXS 2.55
- Revenue
- IPHA $20,831,349.00
- FLXS $437,284,000.00
- Revenue This Year
- IPHA $209.83
- FLXS $8.34
- Revenue Next Year
- IPHA $83.15
- FLXS $4.01
- P/E Ratio
- IPHA N/A
- FLXS $15.55
- Revenue Growth
- IPHA N/A
- FLXS 7.24
- 52 Week Low
- IPHA $1.29
- FLXS $29.38
- 52 Week High
- IPHA $3.51
- FLXS $65.87
- Technical
- Relative Strength Index (RSI)
- IPHA 42.70
- FLXS 57.74
- Support Level
- IPHA $1.71
- FLXS $36.20
- Resistance Level
- IPHA $1.90
- FLXS $40.57
- Average True Range (ATR)
- IPHA 0.08
- FLXS 1.74
- MACD
- IPHA 0.00
- FLXS 0.15
- Stochastic Oscillator
- IPHA 47.62
- FLXS 58.97
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About FLXS Flexsteel Industries Inc.
Flexsteel Industries Inc is a United States-based company that manufactures, imports, and markets residential upholstered wooden furniture products. Its product offerings include sofas, loveseats, chairs, rockers, desks, tables, convertible bedding units, and bedroom furniture. The company's products are intended for use in home, office, hotel, healthcare, and other contract applications. A featured component in the company's upholstered furniture is the durable Blue Steel Spring. It operates in the business segment of Furniture products. The company's furniture products business involves the distribution of manufactured and imported products for residential markets.